Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001641172-25-003110
Filing Date
2025-04-07
Accepted
2025-04-07 21:54:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9680
  Complete submission text file 0001641172-25-003110.txt   11456
Mailing Address C/O IMPRIMIS PHARMACEUTICALS, INC 12264 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address
BAUM MARK L (Filed by) CIK: 0001274282 (see all company filings)

Type: SCHEDULE 13D/A

Mailing Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN
Business Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN 615.733.4731
HARROW, INC. (Subject) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-83793 | Film No.: 25820017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)